Previous meta-analyses showed that high expression of CD133 was responsible for the reduced OS of ovarian cancer, gastric cancer, non-small cell lung cancer and hepatocellular carcinoma patients37, 38, 39, 40. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.